The gold industry standard for risk and cost of drug and vaccine development revisited

Abstract Gold dimensions of pharmaceutical drug development indicate that it takes on average 11.9 years, with an investment around US$ 0.8 Billion, to launch one product on the market. Furthermore, approximately 22% of the drug candidates successfully complete clinical testing. These universally ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2011-08, Vol.29 (35), p.5846-5849
Hauptverfasser:	Pronker, E.S, Weenen, T.C, Commandeur, H.R, Osterhaus, A.D.M.E, Claassen, H.J.H.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Applied microbiology Biological and medical sciences Biomedical Research Classified information Cost Drug development Drug Industry - economics Drug Industry - statistics & numerical data Fundamental and applied biological sciences. Psychology Gold Humans industry Investments - economics Market entry markets Microbiology Pharmaceutical industry Pharmaceutical Preparations - economics Phase transitions Product development Productivity Registration Risk Studies Success Success rate Transition rate Vaccine vaccine development Vaccines Vaccines - economics Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!